These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 2790791
1. Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates. Senter PD, Schreiber GJ, Hirschberg DL, Ashe SA, Hellström KE, Hellström I. Cancer Res; 1989 Nov 01; 49(21):5789-92. PubMed ID: 2790791 [Abstract] [Full Text] [Related]
2. Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate. Senter PD, Saulnier MG, Schreiber GJ, Hirschberg DL, Brown JP, Hellström I, Hellström KE. Proc Natl Acad Sci U S A; 1988 Jul 01; 85(13):4842-6. PubMed ID: 3387440 [Abstract] [Full Text] [Related]
3. Antitumor effects of antibody enzyme conjugates in combination with prodrugs. Senter PD. Front Radiat Ther Oncol; 1990 Jul 01; 24():132-41; discussion 161-5. PubMed ID: 2341048 [No Abstract] [Full Text] [Related]
4. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates. Svensson HP, Vrudhula VM, Emswiler JE, MacMaster JF, Cosand WL, Senter PD, Wallace PM. Cancer Res; 1995 Jun 01; 55(11):2357-65. PubMed ID: 7757987 [Abstract] [Full Text] [Related]
5. Specific activation of the prodrug mitomycin phosphate by a bispecific anti-CD30/anti-alkaline phosphatase monoclonal antibody. Sahin U, Hartmann F, Senter P, Pohl C, Engert A, Diehl V, Pfreundschuh M. Cancer Res; 1990 Nov 01; 50(21):6944-8. PubMed ID: 2170012 [Abstract] [Full Text] [Related]
6. Development of a human xenograft model for the evaluation of monoclonal antibody L6-mitomycin immunoconjugates. Trail PA, Rose WC. In Vivo; 1989 Nov 01; 3(5):319-24. PubMed ID: 2519872 [Abstract] [Full Text] [Related]
7. Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate. Haisma HJ, Boven E, van Muijen M, De Vries R, Pinedo HM. Cancer Immunol Immunother; 1992 Nov 01; 34(5):343-8. PubMed ID: 1540981 [Abstract] [Full Text] [Related]
8. In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate. Wallace PM, Senter PD. Bioconjug Chem; 1991 Nov 01; 2(5):349-52. PubMed ID: 1790175 [Abstract] [Full Text] [Related]
9. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma]. Takahashi T, Yamaguchi T, Yokota T, Kitamura K, Suzuyama H, Honda M, Otsuji E, Sawai K, Sakita M, Kotanagi H. Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 2):931-7. PubMed ID: 2952068 [Abstract] [Full Text] [Related]
10. [In vivo assessment on the therapeutic effects of etoposide, vincristine and mitomycin C against human neuroblastoma]. Kaneko M, Kaneko S, Ohkawa H. Gan To Kagaku Ryoho; 1991 Jun 01; 18(7):1155-61. PubMed ID: 1905121 [Abstract] [Full Text] [Related]
11. Significance of antigen, drug, and tumor cell targets in the preclinical evaluation of doxorubicin, daunorubicin, methotrexate, and mitomycin-C monoclonal antibody immunoconjugates. Dillman RO, Johnson DE, Ogden J, Beidler D. Mol Biother; 1989 Jun 01; 1(5):250-5. PubMed ID: 2515870 [Abstract] [Full Text] [Related]
12. Membrane-bound alkaline phosphatase gene induces antitumor effect by G2/M arrest in etoposide phosphate-treated cancer cells. Kim KY, Cho YJ, Jeon GA, Ryu PD, Myeong JN. Mol Cell Biochem; 2003 Oct 01; 252(1-2):213-21. PubMed ID: 14577595 [Abstract] [Full Text] [Related]
13. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma. Svensson HP, Frank IS, Berry KK, Senter PD. J Med Chem; 1998 Apr 23; 41(9):1507-12. PubMed ID: 9554883 [Abstract] [Full Text] [Related]
14. Antitumor activity of a C-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Geiger T, Müller M, Monia BP, Fabbro D. Clin Cancer Res; 1997 Jul 23; 3(7):1179-85. PubMed ID: 9815797 [Abstract] [Full Text] [Related]
15. An in vivo human tumor xenograft model of etoposide resistance. Rose WC, Basler GA. In Vivo; 1989 Jul 23; 3(4):249-53. PubMed ID: 2519860 [Abstract] [Full Text] [Related]
16. Immunologically specific activation of a cephalosporin derivative of mitomycin C by monoclonal antibody beta-lactamase conjugates. Vrudhula VM, Svensson HP, Senter PD. J Med Chem; 1997 Aug 15; 40(17):2788-92. PubMed ID: 9276025 [Abstract] [Full Text] [Related]
17. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma]. Takahashi T, Sakita M, Yamaguchi T, Kitamura K, Hata K, Noguchi A. Gan To Kagaku Ryoho; 1988 May 15; 15(5):1702-9. PubMed ID: 2967049 [Abstract] [Full Text] [Related]
18. A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16. Weiner LM, Holmes M, Adams GP, LaCreta F, Watts P, Garcia de Palazzo I. Cancer Res; 1993 Jan 01; 53(1):94-100. PubMed ID: 8093231 [Abstract] [Full Text] [Related]
19. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas. Klapdor R, Schwarzenberg O, Kühl JS, Franke N, Bahlo M. Strahlenther Onkol; 1989 Jul 01; 165(7):549-50. PubMed ID: 2501886 [No Abstract] [Full Text] [Related]
20. Enhanced antitumor activity of paclitaxel in combination with the anticarcinoma immunoconjugate BR96-doxorubicin. Trail PA, Willner D, Bianchi AB, Henderson AJ, TrailSmith MD, Girit E, Lasch S, Hellström I, Hellström KE. Clin Cancer Res; 1999 Nov 01; 5(11):3632-8. PubMed ID: 10589780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]